Chase C. Leavitt's Net Worth
$355 Thousand
Who is Chase C. Leavitt?
Chase C. Leavitt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOTIME INC, and Oncternal Therapeutics, Inc..
SEC CIK
Chase C. Leavitt's CIK is 0001777467
Past Insider Trading and Trends
2023 was Chase C. Leavitt's most active year for acquiring shares with 8 total transactions. Chase C. Leavitt's most active month to acquire stocks was the month of September. 2023 was Chase C. Leavitt's most active year for disposing of shares, totalling 6 transactions. Chase C. Leavitt's most active month to dispose stocks was the month of September. 2022 saw Chase C. Leavitt paying a total of $23,280.00 for 170,761 shares, this is the most they've acquired in one year. In 2023 Chase C. Leavitt cashed out on 375,665 shares for a total of $9,922.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOTIME INC (LCTX) Snapshot price: $0.836
General Counsel/SecretaryChase C. Leavitt owns 5,000 units of Common Shares which is worth $4,180.00. In the year 2019 Chase C. Leavitt filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
∞
| 5K |
$1.02 | $5,100.00 | 5K |
Jul 31 - Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47
General Counsel/SecretaryChase C. Leavitt owns 84,758 units of Common Stock which is worth $378,868.26. From 2021 to 2024 Chase C. Leavitt acquired a total of 112,992 shares in Oncternal Therapeutics, Inc. at a cost of $38,705.00, Chase also disposed a total of 28,234 shares of Oncternal Therapeutics, Inc. equalling to $15,795.45.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| -12.26% | -11.84K |
$0.50 | -$5,872.83 | 84.76K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
| -9.64% | -10.30K |
$0.36 | -$3,709.80 | 96.6K |
Jul 3
| |||
Form 4
| +30.52% | 25K |
$0.29 | $7,250.00 | 106.9K |
Apr 12 - Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -6.92% | -6.09K |
$1.02 | -$6,212.82 | 81.9K |
Jan 3
| |||
Form 4
| +96.12% | 43.13K |
—
|
—
| 87.99K |
Jul 28
| |||
Form 4
| +43.04% | 13.5K |
$1.72 | $23,280.00 | 44.87K |
Jan 27 - Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
| +1,991.13% | 29.87K |
—
|
—
| 31.37K |
Jan 3
| |||
Form 4
|
∞
| 1.5K |
$5.45 | $8,175.00 | 1.5K |
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||